Riskpilot← Back to searchSign inGet full accessNB 2017 ApS
APSActiveCVR 38874861Østre Alle 1Activities of holding companies · NACE 6421Est. 2017— employees
Revenue 2025
DKK -5K
+9% vs 2024
EBITDA margin
100.0%
-9% vs 2024
Equity ratio
73.7%
Financial strength
Net profit 2025
DKK -5K
-9% vs 2024
| Revenue | DKK -5K | +9% |
| EBITDA | DKK -5K | -9% |
| Net profit | DKK -5K | -9% |
| Total assets | DKK 100K | -1% |
| Equity | DKK 74K | -6% |
| Employees | — | — |
Legal name
NB 2017 ApS
CVR number
38874861
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
23. august 2017
Share capital
DKK 51.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene, eller af hele direktionen i forening.
Company purpose
Selskabets formål er at foretage investeringer i aktiviteter, som udfører forsknings- og udviklingsaktiviteter med henblik på udvikling af lægemidler og medicinsk udstyr, at levere konsulentydelser i relation dertil, og at udføre sådanne aktiviteter, som direktionen skønsmæssigt måtte finde relaterede hertil, herunder enhver form for investeringsaktivitet.
Address
Østre Alle 1
Phone
+4521431263
Email
niels.behrendt@finsenlab.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -10 | 1 | -2 | -2 | -9 | -4 | -5 | -5 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -10 | 1 | -2 | -2 | -9 | -4 | -5 | -5 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -10 | 1 | -2 | -2 | -9 | -4 | -5 | -5 |
| Net financials | 0 | 0 | 0 | -0 | -0 | 0 | -0 | 0 |
| Profit before tax | -10 | 1 | -2 | -3 | -9 | -4 | -5 | -5 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -10 | 1 | -2 | -3 | -9 | -4 | -5 | -5 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 100 | 104 | 104 | 101 | 101 | 100 | 101 | 100 |
| Equity | 100 | 101 | 99 | 96 | 87 | 84 | 79 | 74 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 3 | 5 | 5 | 14 | 16 | 22 | 26 |
| Total debt | 0 | 3 | 5 | 5 | 14 | 16 | 22 | 26 |
EBITDA margin
-509800.0%
This company
15.8%
Market median
-3226682% vs market
20182025
Equity ratio
73.7%
This company
38.2%
Market median
+93% vs market
20182025
Return on equity
-6.9%
This company
18.4%
Market median
-138% vs market
20182025
Net profit margin
-509800.0%
This company
8.1%
Market median
-6293927% vs market
20182025
Asset turnover
-0.05×
This company
1.12×
Market median
-104% vs market
20182025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20182025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-08-23 – 2018-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NB 2017 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|